vs
Side-by-side financial comparison of RadNet, Inc. (RDNT) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $547.7M, roughly 1.4× RadNet, Inc.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -0.1%, a 2.3% gap on every dollar of revenue. On growth, RadNet, Inc. posted the faster year-over-year revenue change (14.8% vs 2.5%). Over the past eight quarters, RadNet, Inc.'s revenue compounded faster (12.6% CAGR vs 0.9%).
RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
RDNT vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $547.7M | $766.5M |
| Net Profit | $-597.0K | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | 5.1% | 2.3% |
| Net Margin | -0.1% | 2.2% |
| Revenue YoY | 14.8% | 2.5% |
| Net Profit YoY | -111.2% | -3.3% |
| EPS (diluted) | $0.00 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $547.7M | $766.5M | ||
| Q3 25 | $522.9M | $739.6M | ||
| Q2 25 | $498.2M | $812.9M | ||
| Q1 25 | $471.4M | $704.8M | ||
| Q4 24 | $477.1M | $747.5M | ||
| Q3 24 | $461.1M | $775.6M | ||
| Q2 24 | $459.7M | $746.1M | ||
| Q1 24 | $431.7M | $752.6M |
| Q4 25 | $-597.0K | $16.5M | ||
| Q3 25 | $5.4M | $19.9M | ||
| Q2 25 | $14.5M | $20.1M | ||
| Q1 25 | $-37.9M | $17.4M | ||
| Q4 24 | $5.3M | $17.1M | ||
| Q3 24 | $3.2M | $17.0M | ||
| Q2 24 | $-3.0M | $16.1M | ||
| Q1 24 | $-2.8M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | 5.1% | 2.3% | ||
| Q3 25 | 5.2% | 3.5% | ||
| Q2 25 | 6.2% | 3.3% | ||
| Q1 25 | -5.1% | 3.2% | ||
| Q4 24 | 5.1% | 2.5% | ||
| Q3 24 | 7.4% | 2.3% | ||
| Q2 24 | 7.6% | 2.9% | ||
| Q1 24 | 2.6% | 2.3% |
| Q4 25 | -0.1% | 2.2% | ||
| Q3 25 | 1.0% | 2.7% | ||
| Q2 25 | 2.9% | 2.5% | ||
| Q1 25 | -8.0% | 2.5% | ||
| Q4 24 | 1.1% | 2.3% | ||
| Q3 24 | 0.7% | 2.2% | ||
| Q2 24 | -0.6% | 2.2% | ||
| Q1 24 | -0.6% | 1.7% |
| Q4 25 | $0.00 | $0.75 | ||
| Q3 25 | $0.07 | $0.89 | ||
| Q2 25 | $0.19 | $0.87 | ||
| Q1 25 | $-0.51 | $0.74 | ||
| Q4 24 | $0.08 | $0.70 | ||
| Q3 24 | $0.04 | $0.69 | ||
| Q2 24 | $-0.04 | $0.66 | ||
| Q1 24 | $-0.04 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $767.2M | $83.5M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.1B | $910.9M |
| Total Assets | $3.8B | $1.7B |
| Debt / EquityLower = less leverage | 1.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $767.2M | $83.5M | ||
| Q3 25 | $804.7M | $124.9M | ||
| Q2 25 | $833.2M | $126.2M | ||
| Q1 25 | $717.3M | $146.3M | ||
| Q4 24 | $740.0M | $110.5M | ||
| Q3 24 | $748.9M | $145.0M | ||
| Q2 24 | $741.7M | $185.5M | ||
| Q1 24 | $527.0M | $159.1M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $834.6M | — |
| Q4 25 | $1.1B | $910.9M | ||
| Q3 25 | $1.1B | $914.0M | ||
| Q2 25 | $932.3M | $906.4M | ||
| Q1 25 | $898.1M | $901.7M | ||
| Q4 24 | $902.3M | $900.7M | ||
| Q3 24 | $895.3M | $920.9M | ||
| Q2 24 | $881.0M | $924.3M | ||
| Q1 24 | $873.0M | $944.1M |
| Q4 25 | $3.8B | $1.7B | ||
| Q3 25 | $3.7B | $1.7B | ||
| Q2 25 | $3.5B | $1.8B | ||
| Q1 25 | $3.3B | $1.7B | ||
| Q4 24 | $3.3B | $1.7B | ||
| Q3 24 | $3.3B | $1.8B | ||
| Q2 24 | $3.2B | $1.8B | ||
| Q1 24 | $3.0B | $1.8B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | 1.18× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 1.13× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | 0.96× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $84.2M | $30.8M |
| Free Cash FlowOCF − Capex | — | $28.9M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.2M | $30.8M | ||
| Q3 25 | $52.8M | $23.2M | ||
| Q2 25 | $120.3M | — | ||
| Q1 25 | $41.5M | $66.1M | ||
| Q4 24 | $42.5M | $-6.2M | ||
| Q3 24 | $57.4M | $44.8M | ||
| Q2 24 | $116.0M | — | ||
| Q1 24 | $17.1M | $160.2M |
| Q4 25 | — | $28.9M | ||
| Q3 25 | — | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $157.7M |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | 9.75× | 1.17× | ||
| Q2 25 | 8.33× | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | 7.96× | -0.36× | ||
| Q3 24 | 17.89× | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
